SGX Google Yahoo TradingView

IX BIOPHARMA LTD. (42C) SGD 0.35   -2.86% -0.01

Portfolio Watchlist
AllFinancialBuy BackInsider Trading

IX Biopharma

2020-06-29
General Announcement::PRESS RELEASE: IX BIOPHARMA'S XATIVA RECORDS ROBUST UPTAKE FROM INITIAL PRODUCTION RUNS IN AUSTRALIA

IX Biopharma

2020-06-09
General Announcement::Notice of Allowance from United States Patent and Trademark Office for application covering WaferiX

IX Biopharma

2020-05-25
General Announcement::PRESS RELEASE: IX BIOPHARMA COMMENCES SUPPLY OF WAFESIL AND SILCAP IN AUSTRALIA THROUGH TELEMEDICINE

IX Biopharma

2020-05-08
General Announcement::UPDATE ON IMPACT OF COVID-19 ON BUSINESS OPERATIONS

IX Biopharma

2020-05-03
General Announcement::PRESS RELEASE: ENTITY SEES STRONG DEMAND FROM CHINA ON BOTH E-COMMERCE STORES

IX Biopharma

2020-04-28
General Announcement::Press Release: iX Biopharma inks agreement with Cannatrek to supply Xativa to the Australian market

IX Biopharma

2020-04-26
General Announcement::Press Release: Licensing, supply and distribution of Wafesil, sublingual sildenafil wafer, in China

IX Biopharma

2020-04-13
General Announcement::ENTITY EXPANDS NUTRACEUTICAL BUSINESS IN CHINA WITH LAUNCH OF SECOND FLAGSHIP E-COMMERCE STORE

IX Biopharma

2020-04-06
General Announcement::PRESS RELEASE - ENTITY COMMENCES SALE OF NUTRACEUTICALS TO CONSUMERS IN CHINA

IX Biopharma

2020-03-02
General Announcement::CESSATION OF QUARTERLY REPORTING

IX Biopharma

2020-02-11
Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

IX Biopharma

2020-01-30
General Announcement::iX Biopharma Ltd. - Presentation for Phillip Securities - Jan 2020

IX Biopharma

2020-01-17
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

IX Biopharma

2019-12-10
General Announcement::PRESS RELEASE - END-OF-PHASE 2 MEETING WITH THE U.S. FDA REGARDING WAFERMINE

IX Biopharma

2019-12-05
General Announcement::IX BIOPHARMA SECURES AUSTRALIAN CANNABIS MANUFACTURE LICENCE

IX Biopharma

2019-11-27
General Announcement::CHANGE IN COMPOSITION OF THE BOARD AND BOARD COMMITTEES OF THE COMPANY

IX Biopharma

2019-11-27
Change - Announcement of Appointment::Appointment of Non-Executive Independent Director

IX Biopharma

2019-11-26
Annual Reports and Related Documents::

IX Biopharma

2019-11-15
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

IX Biopharma

2019-11-15
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

IX Biopharma

2019-11-05
Financial Statements and Related Announcement::First Quarter Results

IX Biopharma

2019-10-22
General Announcement::IX BIOPHARMA SECURES INDIA PATENT FOR ITS WAFERIX DRUG DELIVERY TECHNOLOGY

IX Biopharma

2019-10-18
REPL::Annual General Meeting::Voluntary

IX Biopharma

2019-09-25
Annual Reports and Related Documents::

IX Biopharma

2019-09-25
Annual General Meeting::Voluntary

IX Biopharma

2019-08-23
Financial Statements and Related Announcement::Full Yearly Results

IX Biopharma

2019-06-21
Annual Reports and Related Documents::

IX Biopharma

2019-05-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

IX Biopharma

2019-05-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

IX Biopharma

2019-05-21
General Announcement::FIRST SUBLINGUAL KETAMINE DRUG FOR TREATMENT OF ACUTE PAIN TO BE EVALUATED IN EOP2 MEETING WITH FDA

IX Biopharma

2019-05-09
Financial Statements and Related Announcement::Third Quarter Results

IX Biopharma

2019-03-29
Change - Announcement of Appointment::Appointment of Chief Operating Officer

IX Biopharma

2019-03-17
Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS

IX Biopharma

2019-02-17
Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS

IX Biopharma

2019-02-11
Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

IX Biopharma

2018-12-14
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

IX Biopharma

2018-11-30
REPL::Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

IX Biopharma

2018-11-16
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

IX Biopharma

2018-11-16
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

IX Biopharma

2018-11-12
General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND REMUNERATION COMMITTEE

IX Biopharma

2018-11-12
Financial Statements and Related Announcement::First Quarter Results

IX Biopharma

2018-11-06
REPL::General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS

IX Biopharma

2018-11-05
General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS

IX Biopharma

2018-10-19
Change - Announcement of Cessation::Retirement of Lead Independent Director

IX Biopharma

2018-10-19
REPL::Annual General Meeting::Voluntary

IX Biopharma

2018-09-26
Annual Reports and Related Documents::

IX Biopharma

2018-09-26
Annual General Meeting::Voluntary

IX Biopharma

2018-09-21
General Announcement::UPDATE ANNOUNCEMENT ON PROPOSED SILDENAFIL RECLASSIFICATION

IX Biopharma

2018-09-05
General Announcement::IX BIOPHARMA REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE CLINICAL EFFICACY TRIAL

IX Biopharma

2018-08-27
Financial Statements and Related Announcement::Full Yearly Results

© 2026 Dividends.sg